Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA splicing is a fundamental process in eukaryotic gene expression involving the removal of introns from pre-mRNA and the joining of exons to form mature mRNA. This process, primarily catalyzed by the spliceosome, is essential for correct protein synthesis and allows for alternative splicing, which generates multiple protein isoforms from a single gene. Aberrant splicing is implicated in various diseases, making the splicing machinery a potential therapeutic target.
Modulation of alternative splicing patterns; targeting spliceosome components or regulatory factors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA Splicing (N/A).